YD Bio Limited (YDES)
NASDAQ:YDES
Want to see YDES full AI Analyst Report?
Total Valuation
YD Bio Limited has a market cap or net worth of $231.48M. The enterprise value is $182.41M.
Market Cap$231.48M
Enterprise Value$182.41M
Share Statistics
YD Bio Limited has 70,789,260 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding70,789,260
Owned by Insiders―
Owned by Institutions0.04%
Financial Efficiency
YD Bio Limited’s return on equity (ROE) is 2.91 and return on invested capital (ROIC) is -43.41%.
Return on Equity (ROE)2.91
Return on Assets (ROA)-0.60
Return on Invested Capital (ROIC)-43.41%
Return on Capital Employed (ROCE)-0.43
Revenue Per Employee149.20K
Profits Per Employee-2.08M
Employee Count4
Asset Turnover0.04
Inventory Turnover0.34
Valuation Ratios
The current PE Ratio of YD Bio Limited is ―. YD Bio Limited’s PEG ratio is 1.25.
PE Ratio―
PS Ratio1362.74
PB Ratio-284.80
Price to Fair Value-284.80
Price to FCF-101.20
Price to Operating Cash Flow-7.86
PEG Ratio1.25
Income Statement
In the last 12 months, YD Bio Limited had revenue of 596.82K and earned -8.31M in profits. Earnings per share was -0.12.
Revenue596.82K
Gross Profit-42.15K
Operating Income-5.27M
Pretax Income-8.31M
Net Income-8.31M
EBITDA-8.10M
Earnings Per Share (EPS)-0.12
Cash Flow
In the last 12 months, operating cash flow was -1.18M and capital expenditures -3.00, giving a free cash flow of -1.18M billion.
Operating Cash Flow-1.18M
Free Cash Flow-1.18M
Free Cash Flow per Share-0.02
Dividends & Yields
YD Bio Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.36
52-Week Price Change-78.06%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)91.42K
Important Dates
YD Bio Limited upcoming earnings date is Apr 30, 2026, After Close (Confirmed).
Last Earnings DateSep 30, 2025
Next Earnings DateApr 30, 2026
Ex-Dividend Date―
Financial Position
YD Bio Limited as a current ratio of 5.88, with Debt / Equity ratio of -0.24%
Current Ratio5.88
Quick Ratio4.74
Debt to Market Cap0.00
Net Debt to EBITDA0.74
Interest Coverage Ratio0.00
Taxes
In the past 12 months, YD Bio Limited has paid -1.53K in taxes.
Income Tax-1.53K
Effective Tax Rate<0.01
Enterprise Valuation
YD Bio Limited EV to EBITDA ratio is -99.63, with an EV/FCF ratio of -100.45.
EV to Sales1.35K
EV to EBITDA-99.63
EV to Free Cash Flow-100.45
EV to Operating Cash Flow-122.38
Balance Sheet
YD Bio Limited has $6.31K in cash and marketable securities with $0.00 in debt, giving a net cash position of $6.31K billion.
Cash & Marketable Securities$6.31K
Total Debt$0.00
Net Cash$6.31K
Net Cash Per Share<$0.01
Tangible Book Value Per Share-$0.08
Margins
Gross margin is 0.00%, with operating margin of -883.31%, and net profit margin of -1392.61%.
Gross Margin0.00%
Operating Margin-883.31%
Pretax Margin-1392.86%
Net Profit Margin-1392.61%
EBITDA Margin-1357.75%
EBIT Margin-1392.86%
Analyst Forecast
The average price target for YD Bio Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast14.61%